Oncolines Technology Platforms for Precision Oncology

Cell-Based Assays to Determine Genetic Drivers and Biological Pathways for Precision Oncology

  • Available on a fee-for-service basis and collaborations via an integrated precision medicine approach.

  • It is our mission to bring improved and novel therapies to the right patient population faster.